Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctioncysteine-type deubiquitinase activity

USP17L21 USP17L20 USP17L19 USP17L18 USP42 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP37 USP10 USP17L6P USP17L22 USP17L15

3.77e-1311423516GO:0004843
GeneOntologyMolecularFunctionubiquitin-like protein peptidase activity

USP17L21 USP17L20 USP17L19 USP17L18 USP42 SENP5 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP37 USP10 USP17L6P USP17L22 USP17L15

5.38e-1313723517GO:0019783
GeneOntologyMolecularFunctiondeubiquitinase activity

USP17L21 USP17L20 USP17L19 USP17L18 USP42 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP37 USP10 USP17L6P USP17L22 USP17L15

1.43e-1212423516GO:0101005
GeneOntologyMolecularFunctioncysteine-type peptidase activity

USP17L21 USP17L20 USP17L19 USP17L18 USP42 SENP5 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP37 USP10 USP17L6P USP17L22 USP17L15

1.28e-1019223517GO:0008234
GeneOntologyMolecularFunctionpeptidase activity

USP17L21 USP17L20 USP17L19 USP17L18 USP42 SENP5 USP17L12 NRDC USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP37 USP10 USP17L6P USP17L22 ENPEP USP17L15 ECE2

9.96e-0565423520GO:0008233
GeneOntologyMolecularFunctionalpha-catenin binding

PKP2 PTPRT CDH1

3.27e-04122353GO:0045294
GeneOntologyBiologicalProcessprotein modification by small protein removal

USP17L21 USP17L20 USP17L19 COPS2 USP17L18 USP42 SENP5 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP37 USP10 USP17L6P USP17L22 USP17L15

5.18e-1414423418GO:0070646
GeneOntologyBiologicalProcessprotein deubiquitination

USP17L21 USP17L20 USP17L19 USP17L18 USP42 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP37 USP10 USP17L6P USP17L22 USP17L15

9.38e-1312523416GO:0016579
GeneOntologyBiologicalProcessprotein modification by small protein conjugation or removal

USP17L21 USP17L20 TRAIP USP17L19 ZZEF1 COPS2 USP17L18 USP42 PEX2 ANAPC16 SENP5 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP37 FANCM USP10 RNF2 LMO7 USP17L6P MAPK9 USP17L22 USP17L15 KDM1A HERC5

1.18e-05100923428GO:0070647
GeneOntologyBiologicalProcesspost-translational protein modification

USP17L21 USP17L20 TRAIP USP17L19 ZZEF1 COPS2 USP17L18 USP42 PEX2 ANAPC16 SENP5 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP37 FANCM USP10 RNF2 LMO7 USP17L6P MAPK9 USP17L22 USP17L15 KDM1A HERC5

3.63e-05107423428GO:0043687
DomainUSP_CS

USP17L21 USP17L20 USP17L19 USP17L18 USP42 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP37 USP10 USP17L22

4.02e-146622514IPR018200
DomainHABP4_PAI-RBP1

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22

4.84e-14162259PF04774
DomainHABP4_PAIRBP1-bd

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22

4.84e-14162259IPR006861
DomainUSP_1

USP17L21 USP17L20 USP17L19 USP17L18 USP42 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP37 USP10 USP17L22

9.62e-147022514PS00972
DomainUCH

USP17L21 USP17L20 USP17L19 USP17L18 USP42 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP37 USP10 USP17L22

1.19e-137122514PF00443
DomainUSP_2

USP17L21 USP17L20 USP17L19 USP17L18 USP42 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP37 USP10 USP17L22

1.19e-137122514PS00973
DomainUSP_3

USP17L21 USP17L20 USP17L19 USP17L18 USP42 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP37 USP10 USP17L22

1.46e-137222514PS50235
DomainUSP_dom

USP17L21 USP17L20 USP17L19 USP17L18 USP42 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP37 USP10 USP17L22

1.46e-137222514IPR028889
DomainPeptidase_C19_UCH

USP17L21 USP17L20 USP17L19 USP17L18 USP42 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP37 USP10 USP17L22

1.46e-137222514IPR001394
DomainARM-type_fold

MON2 CLTCL1 NBEAL1 IFT172 PIK3CG PKP2 UTP20 RIPOR1 CLASP1 VEPH1 APOB FRYL ECPAS VIRMA SIL1

1.64e-0533922515IPR016024
DomainPbH1

PKHD1 SHCBP1L PKHD1L1

3.36e-0562253SM00710
DomainPbH1

PKHD1 SHCBP1L PKHD1L1

3.36e-0562253IPR006626
DomainPectin_lyase_fold/virulence

PKHD1 SHCBP1L PKHD1L1

9.24e-0582253IPR011050
DomainDUF4757

LMO7 LIMCH1

1.44e-0422252PF15949
DomainDUF4757

LMO7 LIMCH1

1.44e-0422252IPR031865
DomainDUF4599

SPATA31A7 SPATA31A3 SPATA31A5

3.50e-04122253PF15371
DomainDUF4599

SPATA31A7 SPATA31A3 SPATA31A5

3.50e-04122253IPR027970
DomainAbi_HHR

ABI1 ABI2

4.30e-0432252PF07815
DomainAbl-interactor_HHR_dom

ABI1 ABI2

4.30e-0432252IPR012849
PathwayREACTOME_RAS_PROCESSING

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

4.03e-124517011MM15671
PathwayREACTOME_UB_SPECIFIC_PROCESSING_PROTEASES

USP17L21 USP17L20 USP17L19 USP17L18 USP42 USP17L12 USP28 USP17L11 USP17L5 USP17L10 USP37 USP10 USP17L6P USP17L22 USP17L15

1.01e-0819117015MM15289
PathwayREACTOME_UB_SPECIFIC_PROCESSING_PROTEASES

USP17L21 USP17L20 USP17L19 USP17L18 USP42 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP37 USP10 USP17L22 USP17L15

7.16e-0822117015M27578
PathwayREACTOME_DEUBIQUITINATION

USP17L21 USP17L20 USP17L19 USP17L18 USP42 USP17L12 USP28 USP17L11 USP17L5 USP17L10 USP37 USP10 USP17L6P USP17L22 USP17L15

6.49e-0726217015MM15286
PathwayREACTOME_DEUBIQUITINATION

USP17L21 USP17L20 USP17L19 USP17L18 USP42 USP17L12 USP28 USP17L11 USP17L24 USP17L5 USP17L10 USP37 USP10 USP17L22 USP17L15

3.37e-0629917015M27574
PathwayREACTOME_MAPK_FAMILY_SIGNALING_CASCADES

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 RASA2 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 IL6ST

1.28e-0431817013MM15278
Pubmed

DUB-1, a deubiquitinating enzyme with growth-suppressing activity.

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

4.25e-1921239118622927
Pubmed

DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes.

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

4.25e-19212391114583620
Pubmed

DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

4.25e-19212391111468161
Pubmed

The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor.

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

4.25e-1921239118756639
Pubmed

Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines.

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

4.25e-19212391112447969
Pubmed

DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway.

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

4.25e-19212391118980247
Pubmed

JAK2 is required for induction of the murine DUB-1 gene.

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

8.45e-1922239119154835
Pubmed

Cdc25A and Dub3 in a high-stakes balancing act.

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

2.62e-18332391220228807
Pubmed

DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes.

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

2.95e-1824239118995226
Pubmed

DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

4.03e-18342391214699124
Pubmed

The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence.

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

4.03e-18342391215780755
Pubmed

Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

4.03e-18342391217109758
Pubmed

Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme.

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

4.03e-18342391220715989
Pubmed

Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation.

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

4.03e-1834239129806828
Pubmed

The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster.

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

4.03e-18342391220403174
Pubmed

USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

4.03e-18342391219188362
Pubmed

Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene.

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

4.03e-18342391211941478
Pubmed

The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

4.03e-18342391220388806
Pubmed

The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling.

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

4.03e-18342391220368735
Pubmed

The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter.

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

4.03e-18342391210936051
Pubmed

The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility.

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

4.03e-18342391221448158
Pubmed

Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

5.24e-18252391121115691
Pubmed

Cytokine-regulated protein degradation by the ubiquitination system.

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

6.09e-18352391216611142
Pubmed

Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

6.09e-18352391221239494
Pubmed

Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice.

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

9.03e-18262391135816173
Pubmed

The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected.

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

9.09e-18362391220147298
Pubmed

Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

1.34e-17372391220228808
Pubmed

Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion.

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

3.97e-17292391132527007
Pubmed

DUX is a non-essential synchronizer of zygotic genome activation.

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

3.78e-14502391131806660
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

ARHGAP32 NCKAP1 BCAS3 DAPK2 FSIP2 BMX CCDC138 PKP2 NHS BICC1 ABI1 CLASP1 CEP162 ESYT1 EPB41L5 FRYL VIRMA ZNF106 LMO7 PHF3 RAI14 LIMCH1 CRYBG3 EXOC4

7.96e-098612392436931259
Pubmed

The testis-specific VAD1.3/AEP1 interacts with β-actin and syntaxin 1 and directs peri-nuclear/Golgi expression with bipartite nucleus localization (BNL) sequence.

SPATA31A7 SPATA31A3 SPATA31A5 SPATA31A1

3.23e-086239420850414
Pubmed

Targeted disruption of the spermatid-specific gene Spata31 causes male infertility.

SPATA31A7 SPATA31A3 SPATA31A5 SPATA31A1

3.23e-086239425930072
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

ZC3H14 EPS8 NCKAP1 BCKDK CHD1 UTP20 LSM11 TRMT1L SDHA FNDC3B ABI1 CLASP1 ESYT1 EPB41L5 ECT2L CCT4 VIRMA ZNF768 KIF20B ORC1 CCNT1 USP10 RNF2 ABI2 BAZ1A PHF3 WDR82 RAI14 DDX20 LIMCH1 KDM1A

4.92e-0814972393131527615
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

TRPM6 NCKAP1 PHB2 CHD1 DBT NCLN UTP20 EEA1 SDHA MGAM2 NPAS2 DNHD1 RALA PSAT1 NRDC ESYT1 CCT4 APOB IDH2 RFC1 ECPAS ZNF768 POLR3A USP10 ERLIN2 RNF2 BAZ1A DDX20 NNT KDM1A

5.78e-0814252393030948266
Pubmed

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.

NRIP1 DCHS2 NCKAP1 CENPE NCLN NEB COPS2 ANKRD28 CLASP1 ECPAS ZNF106 ERLIN2 LMO7 RAI14 MYOM2 LIMCH1 KDM1A

7.64e-084972391736774506
Pubmed

Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.

GEMIN8 CCDC138 ANKRD28 POLD2 VPS4B ATG2B VIRMA CCNT1 ZNF106 DDX20 QSER1 EXOC4

1.34e-072422391234011540
Pubmed

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.

ZC3H14 CENPC PHB2 CHD1 COPS2 PAPOLA TRMT1L DPYSL2 USP28 POLD2 CCT4 RFC1 ECPAS VIRMA NPLOC4 POLR3A CCNT1 USP10 RNF2 BAZ1A PHF3 WDR82 QSER1 KDM1A

1.68e-0710142392432416067
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

NCKAP1 CENPC PHB2 CHD1 ZNF638 PKP2 ANKRD28 UTP20 PGP FNDC3B DPYSL2 RASA2 ESYT1 POLD2 ADNP2 EPB41L5 CCT4 RFC1 KIF20B POLR3A ORC1 CCNT1 BAZ1A WDR82 RAI14 DDX20 KDM1A EXOC4

2.35e-0713532392829467282
Pubmed

An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.

MON2 NCKAP1 IFT172 PHB2 NCLN COPS2 GLI3 PTPRQ ZNF638 ANKRD28 RIPOR1 EEA1 ABI1 CLASP1 ESYT1 ATG2B IDH2 ERLIN2 RNF2 LMO7 GCC2 RAI14 DDX20 QSER1 MUC5AC KDM1A EXOC4

4.99e-0713212392727173435
Pubmed

Majority of cerebrospinal fluid-contacting neurons in the spinal cord of C57Bl/6N mice is present in ectopic position unlike in other studied experimental mice strains and mammalian species.

SPATA31A7 SPATA31A3 SPATA31A5 CRB1 SPATA31A1

5.61e-0724239532212159
Pubmed

Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis.

EPS8 CLTCL1 TRO PCDH15 DPYSL2 ESYT1 CCT4 ERLIN2 LMO7 CDH1

1.11e-061952391017110338
Pubmed

A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.

MON2 NCKAP1 COPS2 PKP2 ANKRD28 SDHA DPYSL2 ABI1 NRDC ESYT1 RFC1 ECPAS BAZ1A NNT KDM1A EXOC4

1.98e-065602391635241646
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

PAPOLA USP42 ZNF638 UTP20 RIPOR1 GCFC2 CLASP1 RFC1 ECPAS VIRMA ZNF768 PITPNM1 USP10 ZNF106 LMO7 PHF3 DDX20 LIMCH1 KAT6B

2.03e-067742391915302935
Pubmed

Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.

NCKAP1 BCAS3 TRO NFIL3 ANKRD28 UTP20 TRMT1L TCF4 ABI1 USP28 ESYT1 ECPAS RNF2 ABI2 BAZ1A QSER1 MAPK9 KDM1A HERC5 MGME1

2.33e-068572392025609649
Pubmed

RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.

ARHGAP32 GGA3 GLI3 ZNF638 NHS ESYT1 ZDHHC5 EPB41L5 TENM1 CRYBG3 EXOC4

2.37e-062632391134702444
Pubmed

Analysis of mouse embryonic patterning and morphogenesis by forward genetics.

NCKAP1 IFT172 ABI1 EPB41L5 KIF20B

2.98e-0633239515755804
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

ZC3H14 NCKAP1 CHD1 ZNF638 ANKRD28 UTP20 SDHA DPYSL2 FRYL RFC1 ECPAS VIRMA PHF3 DDX20 NNT KDM1A HERC5

3.28e-066532391722586326
Pubmed

USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.

CENPE NEB FAT2 FAM186A EEA1 SDHA DNHD1 RFC1 VIRMA RAI14

5.67e-062342391036243803
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

ZC3H14 DBT PAPOLA PKP2 NHS ANKRD28 TRMT1L SDHA PSAT1 POLD2 VPS4B CCT4 RFC1 CCNT1 USP10 ERLIN2 RNF2 LMO7 PHF3 WDR82 RAI14 LIMCH1 CDH1 KDM1A

6.19e-0612472392427684187
Pubmed

Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.

ZC3H14 PP2D1 ANKRD28 MANSC4 NCR2 POLN TRIM36 BICC1 NPAS2 FNDC3B TCF4 NRDC ABCB5 FABP12 PKHD1L1 GCC2 SEMA3E

6.28e-066862391729987050
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

SCN11A CLTCL1 CENPC TRO PHB2 NEB GPALPP1 FAM186A PKHD1 TTLL1 EEA1 TOP1MT RALA ABCB5 CCT4 APOB ERLIN2 RNF2 LMO7 BAZ1A TENM1 MYOM2 LIMCH1 CDH1 RPL3L PCDHGA8

7.92e-0614422392635575683
Pubmed

Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.

ANKRD28 ECPAS GCC2 KAT6B PCDHGA8 SEMA3E PDZD2

7.99e-0610423979205841
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

ZC3H14 CHD1 GGA3 GPALPP1 PAPOLA ZNF638 ANKRD28 DPYSL2 PSAT1 USP28 ESYT1 ATG2B CCT4 RFC1 NPLOC4 CCNT1 USP10 BAZ1A RAI14 HERC5

8.31e-069342392033916271
Pubmed

BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.

ARHGAP32 ATP7A NCKAP1 PHB2 PKP2 SDHA RALA ESYT1 ATG2B ZDHHC5 EPB41L5 CCT4 ECPAS NPLOC4 RAI14 CRYBG3 EXOC4

9.46e-067082391739231216
Pubmed

Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation.

ZNF77 CRB1 LIMCH1 CRYBG3 MUC5AC IL6ST

9.75e-0671239633541421
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

MON2 ARHGAP32 CENPC BCKDK DBT CCDC138 ZNF638 NHS ANKRD28 PGP TRIM36 PSAT1 CEP162 ZDHHC5 CCT4 PTPRT ABI2 WDR82 RAI14 CRYBG3 MAPK9

1.35e-0510492392127880917
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

MON2 DLGAP2 ARHGAP32 NCKAP1 BCAS3 BCKDK PHB2 DBT NCLN ANKRD28 SDHA RALA DPYSL2 ABI1 ATG2B CCT4 IDH2 PITPNM1 ERLIN2 ABI2 TENM1 CRYBG3

1.45e-0511392392236417873
Pubmed

An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.

MON2 CENPE CHD1 ZNF638 ANKRD28 ANAPC16 DPYSL2 GCFC2 CLASP1 VPS4B EPB41L5 ZNF106 ERLIN2 PHF3 DDX20 TYW1 QSER1

1.48e-057332391734672954
Pubmed

A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.

MON2 IFT172 CHD1 NCLN PEX2 ANKRD28 SDHA SEMG1 DPYSL2 NRDC CLASP1 ESYT1 EPB41L5 CCT4 ECPAS NPLOC4 SIL1 ERLIN2 MAPK9 KDM1A

1.52e-059742392028675297
Pubmed

Structure and control of the actin regulatory WAVE complex.

NCKAP1 ABI1 ABI2

1.75e-058239321107423
Pubmed

FERM protein EPB41L5 is a novel member of the mammalian CRB-MPP5 polarity complex.

EPB41L5 CRB1 CDH1

1.75e-058239317920587
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

ARHGAP11A ZZEF1 GGA3 USP28 CEP162 ECPAS NPLOC4 USP10 LMO7 PCNX1 RAI14 KAT6B KDM1A SEMA3E

2.04e-055292391414621295
Pubmed

Human and mouse proteases: a comparative genomic approach.

USP42 USP28 USP37 USP10 USP17L6P USP17L15

2.09e-0581239612838346
Pubmed

A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.

MON2 CLTCL1 BCKDK PHB2 NCLN ARHGAP11A COPS2 ANKRD28 TRMT1L SDHA PSAT1 ESYT1 CCT4 IDH2 RFC1 ECPAS NPLOC4 POLR3A USP10 ERLIN2 LMO7 DDX20 LIMCH1 HERC5 EXOC4

2.25e-0514402392530833792
Pubmed

The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.

ZC3H14 CENPE TRAIP BCKDK DBT UTP20 TRMT1L CLASP1 RFC1 VIRMA ZNF768 KIF20B USP10 BAZ1A PHF3 HERC5 EXOC4

2.29e-057592391735915203
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

MON2 NCKAP1 TRO IFT172 GGA3 RIPOR1 CLASP1 VIRMA PHF3 GCC2 LIMCH1 PDZD2

2.84e-054072391212693553
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

BCKDK BCL7B PHB2 PKP2 EEA1 RALA CLASP1 ESYT1 EPB41L5 APOB RFC1 VIRMA NPLOC4 USP10 RNF2 LMO7 BAZ1A PHF3 WDR82 RAI14 DDX20 LIMCH1 MUC5AC MGME1

2.90e-0513712392436244648
Pubmed

Comparative mapping in the beige-satin region of mouse chromosome 13.

BMP6 GLI3 RALA

3.71e-051023939027500
Pubmed

Abi1 is essential for the formation and activation of a WAVE2 signalling complex.

NCKAP1 NEB ABI1

3.71e-0510239315048123
Pubmed

Expression screening of a yeast artificial chromosome contig refines the location of the mouse H3a minor histocompatibility antigen gene.

ZNF106 NNT EPB42

3.71e-051023939670959
Pubmed

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.

EPS8 ARHGAP32 ATP7A NHS SDHA ABI1 ESYT1 ZDHHC5 EPB41L5 ABI2 RAI14 EXOC4

3.94e-054212391236976175
Pubmed

PI(3)Kgamma has an important context-dependent role in neutrophil chemokinesis.

ITGAM PIK3CG

4.70e-052239217173040
Pubmed

Regulation of the epithelial Mg2+ channel TRPM6 by estrogen and the associated repressor protein of estrogen receptor activity (REA).

TRPM6 PHB2

4.70e-052239219329436
Pubmed

c-Jun N-terminal kinase 2 (JNK2) enhances cell migration through epidermal growth factor substrate 8 (EPS8).

EPS8 MAPK9

4.70e-052239221357683
Pubmed

The deubiquitinase USP28 stabilizes LSD1 and confers stem-cell-like traits to breast cancer cells.

USP28 KDM1A

4.70e-052239224075993
Pubmed

Serine Biosynthesis Is a Metabolic Vulnerability in IDH2-Driven Breast Cancer Progression.

PSAT1 IDH2

4.70e-052239233500247
Pubmed

Elevated RalA activity in the hippocampus of PI3Kγ knock-out mice lacking NMDAR-dependent long-term depression.

PIK3CG RALA

4.70e-052239223433113
Pubmed

Integrity of SOS1/EPS8/ABI1 tri-complex determines ovarian cancer metastasis.

EPS8 ABI1

4.70e-052239221118970
Pubmed

Targeted inhibition of CD47-SIRPα requires Fc-FcγR interactions to maximize activity in T-cell lymphomas.

ITGAM FCER1G

4.70e-052239231383641
Pubmed

USP10 promotes the progression of triple-negative breast cancer by enhancing the stability of TCF4 protein.

TCF4 USP10

4.70e-052239237863330
Pubmed

Regulation of actin cytoskeleton architecture by Eps8 and Abi1.

EPS8 ABI1

4.70e-052239216225669
Pubmed

LSD1-Mediated Epigenetic Reprogramming Drives CENPE Expression and Prostate Cancer Progression.

CENPE KDM1A

4.70e-052239228916652
Pubmed

The roles and prognostic significance of ABI1-TSV-11 expression in patients with left-sided colorectal cancer.

EPS8 ABI1

4.70e-052239234031495
Pubmed

NFIL3 aggravates human coronary artery endothelial cell injury by promoting ITGAM transcription in Kawasaki disease.

ITGAM NFIL3

4.70e-052239237933872
Pubmed

Role for the Abi/wave protein complex in T cell receptor-mediated proliferation and cytoskeletal remodeling.

ABI1 ABI2

4.70e-052239216401422
Pubmed

The Abl interactor proteins localize to sites of actin polymerization at the tips of lamellipodia and filopodia.

ABI1 ABI2

4.70e-052239211516653
Pubmed

Transcriptome analysis of mouse stem cells and early embryos.

MON2 ARHGAP32 CENPE BCAS3 NHS ANAPC16 ZNF426 RAD54L ZNF106 WDR82 MYB

4.79e-053632391114691545
Pubmed

Transcription factor Foxp3 and its protein partners form a complex regulatory network.

DBT ZNF638 TRMT1L CCT4 MLLT10 VIRMA KIF20B ORC1 BAZ1A PHF3 KDM1A

5.68e-053702391122922362
Pubmed

Faciogenital Dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stability.

PHB2 SDHA DPYSL2 PSAT1 CCT4 LMO7 RAI14 LIMCH1

5.69e-05191239833762435
Pubmed

MYC multimers shield stalled replication forks from RNA polymerase.

ZC3H14 CENPC PHB2 CHD1 ARHGAP11A USP42 ZNF638 UTP20 USP28 ESYT1 CCT4 RFC1 KIF20B ORC1 USP10 ZNF106 RNF2 PHF3 KDM1A

6.09e-059892391936424410
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

MON2 EPS8 NRIP1 CENPE CLASP1 USP28 KIF20B LMO7 DDX20 CRYBG3 MAPK9 KDM1A ZMYM6 EXOC4

6.41e-055882391438580884
Pubmed

OTUD6A Is an Aurora Kinase A-Specific Deubiquitinase.

USP42 USP28 USP37 USP10

6.72e-0532239433669244
Pubmed

Intracellular substrates of brain-enriched receptor protein tyrosine phosphatase rho (RPTPrho/PTPRT).

PTPRQ PTPRT CDH1

6.73e-0512239316973135
Pubmed

Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.

EPS8 NCKAP1 CCDC138 PKP2 ANKRD28 CLASP1 CEP162 FRYL ECPAS USP10 ERLIN2 LMO7

6.84e-054462391224255178
Pubmed

USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities.

USP17L21 USP17L20 USP17L19 USP17L18 FAT2 SHE USP17L12 USP17L11 USP17L5 USP17L10 RNF2 USP17L6P USP17L22 NNT USP17L15

7.49e-056742391537196079
Pubmed

Morphogenesis of the trachea and esophagus: current players and new roles for noggin and Bmps.

GLI3 RARA CDH1

8.71e-0513239316916379
Pubmed

Oct4 links multiple epigenetic pathways to the pluripotency network.

DBT CCT4 MLLT10 RFC1 RNF2 PHF3 RAI14 KDM1A

8.72e-05203239822083510
Pubmed

Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.

ZC3H14 CHD1 GEMIN8 ZNF638 UTP20 TRMT1L CCT4 RFC1 CCNT1 USP10 ERLIN2 LMO7 BAZ1A PHF3 WDR82 RAI14 DDX20

8.85e-058472391735850772
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

CENPC CHD1 ARHGAP11A FSIP2 ADNP2 RFC1 KIF20B CCNT1 RNF2 BAZ1A PHF3 WDR82 QSER1 KDM1A

9.11e-056082391436089195
Pubmed

Systematic identification of factors for provirus silencing in embryonic stem cells.

NCKAP1 ANKRD28 NRDC RFC1 DDX20 CDH1 KDM1A

9.59e-05153239726365490
Cytoband4p16.1

USP17L21 USP17L20 USP17L19 USP17L18 SLC2A9 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

2.74e-1679238134p16.1
CytobandEnsembl 112 genes in cytogenetic band chr4p16

USP17L21 USP17L20 USP17L19 USP17L18 POLN EVC2 SLC2A9 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

9.63e-1322223815chr4p16
GeneFamilyCadherin related

DCHS2 CDHR2 FAT2 PCDH15

8.95e-0617146424
CoexpressionMADAN_DPPA4_TARGETS

USP17L21 USP17L20 USP17L19 USP17L18 SHE USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

1.73e-118623512MM1312
CoexpressionGRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN

USP17L21 USP17L20 USP17L19 USP17L18 PKP2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

4.08e-1011223512MM1095
CoexpressionGERY_CEBP_TARGETS

USP17L21 USP17L20 USP17L19 USP17L18 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

2.29e-0716023511MM1155
CoexpressionDAZARD_RESPONSE_TO_UV_NHEK_DN

NRIP1 CENPC CHD1 MAP3K5 FAT2 ZNF638 NPAS2 CLASP1 FRYL BAZ1A PHF3 SLC25A44 WDR82 KAT6B

6.17e-0730023514M8702
CoexpressionDAZARD_UV_RESPONSE_CLUSTER_G6

CENPC MAP3K5 FAT2 ZNF638 NPAS2 CLASP1 FRYL BAZ1A PHF3 KAT6B

7.94e-0714523510M1810
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

ZC3H14 EPS8 NRIP1 NCKAP1 CENPC CENPE CHD1 ARHGAP11A ZZEF1 ZNF638 ANKRD28 UTP20 ZBTB18 RALA ABI1 CLASP1 FRYL KIF20B RNF2 BAZ1A PHF3 GCC2 CRYBG3 KAT6B

8.97e-0785623524M4500
CoexpressionMARSON_BOUND_BY_FOXP3_STIMULATED

USP17L21 NRIP1 NCKAP1 CENPC USP17L20 CHD1 USP17L19 ARHGAP11A MAP3K5 USP17L18 EEA1 ZNF426 LETM2 DPYSL2 USP17L12 NRDC USP17L11 USP17L5 USP17L10 ECPAS FAF1 SIL1 USP10 USP17L6P USP17L22 USP17L15 MGME1

1.41e-06107223527MM1031
CoexpressionGRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP

USP17L21 CENPE USP17L20 USP17L19 DBT USP17L18 SERINC3 RIPOR1 TTLL1 USP17L12 USP17L11 USP17L5 USP17L10 PITPNM1 USP17L6P MAPK9 USP17L22 USP17L15 EXOC4

6.76e-0664723519MM981
CoexpressionGSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_45MIN_UP

MON2 BCAS3 COPS2 PIK3CG TMEM106C ANKRD28 EEA1 CEP162 CRYBG3 NNT

1.41e-0520023510M6618
CoexpressionGSE3565_DUSP1_VS_WT_SPLENOCYTES_UP

DAPK2 ITGA1 ITGAM GVINP1 PIK3CG NFIL3 EEA1 ESM1 IL1RL1

1.74e-051632359M6329
CoexpressionLAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE

TRPM6 BCAS3 PKHD1 NHS BICC1 FNDC3B CLASP1 FAF1 LIMCH1 EXOC4

1.98e-0520823510M39233
CoexpressionGSE32901_NAIVE_VS_TH1_CD4_TCELL_DN

CHD1 TOP1MT RAD54L ADNP2 RFC1 KIF20B ZNF106 ABI2 EXOC4

2.42e-051702359M8926
CoexpressionHAMAI_APOPTOSIS_VIA_TRAIL_UP

NRIP1 CENPC CENPE CHD1 ARHGAP11A GPALPP1 ZNF638 EEA1 RALA TCF4 RFC1 KIF20B BAZ1A PHF3 GCC2 RAI14 QSER1 CDH1

2.92e-0565623518M18979
CoexpressionLAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2

BCAS3 TRPM3 PCDH15 PKHD1 NHS SLC2A9 SLC17A1 ENPEP EXOC4 PDZD2

3.32e-0522123510M39222
CoexpressionGSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP

DCHS2 FMO6P ZNF506 EEA1 ZBTB18 NPAS2 DNHD1 IL6ST MYB

7.35e-051962359M3106
CoexpressionAIZARANI_LIVER_C20_LSECS_3

NRIP1 RIPOR1 EEA1 FNDC3B RALA TCF4 BAZ1A RAI14 IL1RL1 LIMCH1 IL6ST

7.84e-0529523511M39121
CoexpressionGSE22443_IL2_VS_IL12_TREATED_ACT_CD8_TCELL_DN

ATP7A RAD54L RALA POLD2 RFC1 FANCM WDR82 NNT KDM1A

8.58e-052002359M8218
CoexpressionCUI_TCF21_TARGETS_2_DN

ATP7A NBEAL1 DBT GVINP1 USP42 NFIL3 SERINC3 SHE RIPOR1 TOP1MT FNDC3B DPYSL2 RASA2 FRYL ECPAS GRM7 LMO7 MYOM2 IL6ST SEMA3E

9.55e-0585423520M1533
CoexpressionAtlasFacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3

CENPC CENPE CHD1 GLI3 ZNF638 ANKRD28 TRMT1L EPB41L5 MLLT10 USP37 ECPAS FANCM KIF20B ZNF106 ABI2 BAZ1A PHF3

4.27e-0553222017Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlasDevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#3_top-relative-expression-ranked_1000

NRIP1 PKP2 FAM234B WNT9B AP1M2 PDE8B TENM1 MYB

4.59e-051242208gudmap_developingKidney_e15.5_cortic collect duct_1000_k3
CoexpressionAtlasDevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#2_top-relative-expression-ranked_500

PKP2 FAM234B WNT9B AP1M2 EPB41L5 PDE8B CDH1

5.19e-05932207gudmap_developingKidney_e15.5_Medullary collecting duct_500_k2
CoexpressionAtlasDevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000

NRIP1 ARHGAP32 NBEAL1 CHD1 EFEMP1 PAPOLA PKHD1 PKP2 FAM234B PSAT1 VEPH1 WNT9B AP1M2 EPB41L5 PHF3 PDE8B TENM1 LIMCH1 CDH1 IL6ST MYB

5.89e-0577422021gudmap_developingKidney_e15.5_cortic collect duct_1000
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DAPK2 EFEMP1 TRPM3 PTPRQ PKHD1 FMO2 VEPH1 EPB41L5 PLEKHG4B LMO7 LIMCH1 CDH1 SEMA3E

1.22e-111792321304ce3673e46606f63d9c87bcba3a64c96817d812
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DAPK2 EFEMP1 TRPM3 PTPRQ PKHD1 FMO2 VEPH1 EPB41L5 PLEKHG4B LMO7 LIMCH1 CDH1 SEMA3E

1.40e-1118123213b45b11428d13950369347e051d4d517efb2bd4fd
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DAPK2 EFEMP1 TRPM3 PTPRQ PKHD1 FMO2 VEPH1 EPB41L5 PLEKHG4B LMO7 LIMCH1 CDH1 SEMA3E

1.97e-11186232133aebe163799109ffc67e4e10ee47c2dd0886a92c
ToppCellControl_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type

NBEAL1 DAPK2 EFEMP1 TRPM3 PTPRQ PKHD1 FMO2 VEPH1 EPB41L5 LMO7 LIMCH1 CDH1 SEMA3E

4.33e-111982321385f424cd9bb3117c9e322031024aabb87696ce47
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DAPK2 EFEMP1 TRPM3 PTPRQ PKHD1 FMO2 POLD2 VEPH1 LMO7 CDH1 RPL3L SEMA3E

5.62e-11161232121e17a993126e1f2a25ee7dfbb95a74ccb2a26791
ToppCellControl-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DAPK2 MAP3K5 TRPM3 PTPRQ PKHD1 FMO2 VEPH1 EPB41L5 PLEKHG4B LMO7 LIMCH1 CDH1

1.69e-10177232129af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1-AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

DAPK2 EFEMP1 TRPM3 PTPRQ PKHD1 FMO2 POLD2 VEPH1 AP1M2 LMO7 LIMCH1 CDH1

6.17e-10198232125a85c286f79cde5811d2595a3397c6fb7685adee
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

NBEAL1 DAPK2 EFEMP1 TRPM3 PTPRQ PKHD1 FMO2 VEPH1 LMO7 LIMCH1 CDH1 SEMA3E

6.17e-1019823212b598ab958e31f1e98bd06dc0097b58ac3a3f90a3
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

NBEAL1 DAPK2 EFEMP1 TRPM3 PTPRQ PKHD1 FMO2 VEPH1 EPB41L5 LMO7 LIMCH1 CDH1

6.53e-1019923212d43c605a4ff221cf78d91678c15d2ad20f831c7f
ToppCellLPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

NBEAL1 DAPK2 EFEMP1 TRPM3 PTPRQ PKHD1 FMO2 VEPH1 EPB41L5 LMO7 CDH1 SEMA3E

6.92e-1020023212ddfb1f006365bf16203ee49f20200f68220cc288
ToppCellControl-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DAPK2 TRPM3 PTPRQ PKHD1 FMO2 VEPH1 EPB41L5 PLEKHG4B LMO7 LIMCH1 CDH1

2.64e-0917823211aa7d43c655df493f1330a5001efaa484e4a19f69
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DAPK2 EFEMP1 TRPM3 PTPRQ PKHD1 FMO2 VEPH1 PLEKHG4B LMO7 CDH1 SEMA3E

3.96e-0918523211c82eab551f65ecebe6db908eda9f9eb3414693c7
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DAPK2 MAP3K5 TRPM3 PKHD1 FMO2 VEPH1 EPB41L5 PLEKHG4B LMO7 LIMCH1 CDH1

4.43e-091872321158d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCellrenal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group

BCAS3 TRPM3 PKHD1 NHS BICC1 FNDC3B SLC2A9 FAF1 SLC17A1 EXOC4 PDZD2

5.83e-0919223211e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCellControl_saline-Epithelial_alveolar-AT_1|Control_saline / Treatment groups by lineage, cell group, cell type

DAPK2 EFEMP1 PTPRQ PKHD1 FMO2 VEPH1 EPB41L5 LMO7 LIMCH1 CDH1 SEMA3E

8.04e-09198232119b161285df7a4e51618f3517cfc5b8221ba55786
ToppCellControl_saline-Epithelial_alveolar-AT_1-AT1|Control_saline / Treatment groups by lineage, cell group, cell type

DAPK2 EFEMP1 FMO2 POLD2 VEPH1 AP1M2 EPB41L5 LMO7 LIMCH1 CDH1 SEMA3E

8.04e-09198232119f972f217d2c39d4c0f7d0d4227d0fffe8535b9d
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

DAPK2 EFEMP1 TRPM3 PTPRQ PKHD1 FMO2 VEPH1 EPB41L5 LMO7 LIMCH1 CDH1

8.92e-09200232118683445ad5b70748c4a1f12eb77d47623085147e
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NEB TRPM3 PTPRQ PCDH15 PKHD1 APOB PKHD1L1 ASXL3 TENM1 MYOM2

4.78e-08184232102cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NEB TRPM3 PTPRQ PCDH15 PKHD1 APOB PKHD1L1 ASXL3 TENM1 MYOM2

4.78e-08184232102b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor

DAPK2 PTPRQ FMO2 VEPH1 EPB41L5 LMO7 LIMCH1 CDH1 SEMA3E PDZD2

4.78e-0818423210561592edc3083fad41b91811151b442207c65dd9
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NEB TRPM3 PTPRQ PCDH15 PKHD1 APOB PKHD1L1 ASXL3 TENM1 MYOM2

4.78e-0818423210ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

TRPM3 PCDH15 PKHD1 NHS NPAS2 PSAT1 SLC2A9 SLC17A1 ENPEP PDZD2

5.30e-08186232105784d255e9ca449d375d81938d0fbbd8a7eb44f6
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

DAPK2 PTPRQ PKHD1 VEPH1 EPB41L5 LMO7 RAI14 LIMCH1 CDH1 SEMA3E

6.47e-08190232108aea807a2bcf0b653b4de6202b6ecb0f0683cc2e
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

TRPM3 PCDH15 PKHD1 NHS BICC1 NPAS2 SLC2A9 SLC17A1 ENPEP PDZD2

6.80e-08191232101c1d13144259b998d4a0e85142f7afef2ef1e63f
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

TRPM3 PCDH15 PKHD1 NHS BICC1 NPAS2 SLC2A9 SLC17A1 ENPEP PDZD2

6.80e-08191232103c464645d0e7e423f791bd63bf5bcf11f6b590d3
ToppCellDividing_Macrophages-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

CENPE TRAIP ARHGAP11A ITGAM TMEM106C PKP2 DPYSL2 KIF20B ORC1 HERC5

7.14e-0819223210741bd0c2b0a7ce3fcb1610ce8bdacaf9a803c212
ToppCellControl_saline-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|Control_saline / Treatment groups by lineage, cell group, cell type

DAPK2 EFEMP1 FMO2 POLD2 VEPH1 AP1M2 EPB41L5 LMO7 LIMCH1 CDH1

9.52e-0819823210827aa9d919bf6d670961e5501e17d351676127e3
ToppCellParenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

EPS8 ARHGAP32 DAPK2 VEPH1 EPB41L5 LMO7 RAI14 LIMCH1 CDH1 PDZD2

9.98e-08199232105cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCellLPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

DAPK2 EFEMP1 PTPRQ PKHD1 FMO2 VEPH1 EPB41L5 LMO7 CDH1 SEMA3E

9.98e-08199232101c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

DAPK2 EFEMP1 TRPM3 PTPRQ PKHD1 FMO2 VEPH1 LMO7 LIMCH1 CDH1

9.98e-0819923210a270630626df614f8605abddb7dee7c4d74f6149
ToppCellControl-Epithelial_alveolar-AT_1-AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DAPK2 TRPM3 PTPRQ PKHD1 FMO2 POLD2 VEPH1 LMO7 CDH1

4.18e-0717823291817bc520f3d23da8c0fa09bba50ae703a820cb1
ToppCellCOVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type

TRPM3 PKHD1 NHS BICC1 SLC2A9 SLC17A1 UGT2A3 TENM1 ENPEP

4.59e-071802329358923e4228035a3e90e2957392089219e90dcd7
ToppCellCOVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type

CDHR2 TRPM3 PKHD1 NHS SLC2A9 SLC17A1 UGT2A3 TENM1 ENPEP

4.81e-0718123296980ea624151da32b7f537f263e40fcb87a02e81
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DAPK2 EFEMP1 TRPM3 PKHD1 FMO2 VEPH1 AP1M2 LMO7 CDH1

5.03e-071822329cc79e0cc21e2fdc4ef77f052818d27b9f707aec1
ToppCellCOVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type

TRPM3 PKHD1 NHS BICC1 SLC2A9 SLC17A1 UGT2A3 TENM1 ENPEP

5.27e-0718323296878d14026c3df6aa12e45dfad94b32fa9d9b0b7
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DAPK2 EFEMP1 TRPM3 PKHD1 FMO2 VEPH1 AP1M2 CDH1 SEMA3E

5.27e-071832329274483009b309289e4cb84beedf6806430db6ff6
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DAPK2 EFEMP1 TRPM3 PTPRQ PKHD1 FMO2 VEPH1 LMO7 CDH1

5.27e-071832329ff6dde877659cde9daa3263db0932c9c9ef1adac
ToppCellLPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DAPK2 TRPM3 PKHD1 FMO2 VEPH1 PLEKHG4B LMO7 LIMCH1 CDH1

5.52e-07184232942ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCellCOVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type

EPS8 TRPM3 PKHD1 NHS BICC1 SLC2A9 SLC17A1 UGT2A3 ENPEP

5.52e-07184232951ed1ebfdef45149541917c66cbacad87072e51f
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DAPK2 EFEMP1 TRPM3 PKHD1 FMO2 VEPH1 AP1M2 LMO7 CDH1

5.77e-0718523293bef59cc0aa939d2a7e52f0f6c61bc00528fe50b
ToppCellControl-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DAPK2 TRPM3 PKHD1 FMO2 VEPH1 EPB41L5 LMO7 LIMCH1 CDH1

5.77e-0718523293937e026add96a396122139daf8011cfbc60e75c
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DAPK2 TRPM3 PKHD1 FMO2 VEPH1 PLEKHG4B LMO7 LIMCH1 CDH1

6.04e-0718623294e94158db52df41d71e67b02b9895a358eebee0f
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

DAPK2 EFEMP1 PTPRQ VEPH1 EPB41L5 PLEKHG4B LMO7 LIMCH1 SEMA3E

6.32e-0718723294ae7465174e0295d2c3b614b321a3b2f514dd22a
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TRPM3 PCDH15 PKHD1 NHS SLC2A9 SLC17A1 TENM1 ENPEP PDZD2

6.32e-071872329dcf6475ece5b34d9d58a0d1f51c18acedb19c119
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TRPM3 PCDH15 PKHD1 NHS SLC2A9 SLC17A1 TENM1 ENPEP PDZD2

6.32e-071872329f1356273bd3587b6883295edf15cb9cdb706c057
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor

DAPK2 PTPRQ FMO2 EPB41L5 LMO7 LIMCH1 CDH1 SEMA3E PDZD2

6.32e-07187232977f78aec946bc6bd85c29aee9ca978ce49f853a3
ToppCellControl-Epithelial_cells|Control / group, cell type (main and fine annotations)

EPS8 NBEAL1 DAPK2 VEPH1 EPB41L5 LMO7 LIMCH1 CDH1 PDZD2

6.60e-071882329707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCellRA-10._Endothelium_II|World / Chamber and Cluster_Paper

ITGA1 BMP6 BMX TRPM3 PCDH15 TCF4 PKHD1L1 RAI14 IL6ST

6.90e-07189232975c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

DAPK2 PTPRQ FMO2 EPB41L5 LMO7 LIMCH1 CDH1 SEMA3E PDZD2

7.21e-07190232930b50d183d7649146eb1e79b47ba897355f1998a
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

DAPK2 PTPRQ PKHD1 VEPH1 EPB41L5 LMO7 LIMCH1 CDH1 PDZD2

7.54e-071912329ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCellEpithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor

NBEAL1 DAPK2 PKHD1 VEPH1 EPB41L5 LMO7 RAI14 LIMCH1 CDH1

7.54e-071912329d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCellLPS-antiTNF-Unknown-Endothelial-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

B4GALNT1 ARHGAP11A SHE POLN FANCM KIF20B PHF3 HAS1

8.21e-071422328b66f9602dba30d1d4fbcc49ceb112eb5bd916ba1
ToppCellBronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DAPK2 PTPRQ FMO2 VEPH1 EPB41L5 LMO7 LIMCH1 CDH1 SEMA3E

8.96e-071952329a71ba5e4043e2d35a45a2c60a96b087e31832345
ToppCellnucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

EPS8 DAPK2 VEPH1 EPB41L5 LMO7 RAI14 LIMCH1 CDH1 PDZD2

8.96e-0719523299406866f99555198a9be311fbd65751b70f35446
ToppCellBronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FAT2 GLI3 PKP2 NHS NPAS2 TCF4 SLC2A9 NTF3 ASXL3

9.75e-0719723291e915957ea6a4550ecb9d6ee4b232aa5800faf20
ToppCellControl_saline-Epithelial_alveolar|Control_saline / Treatment groups by lineage, cell group, cell type

DAPK2 EFEMP1 FMO2 VEPH1 AP1M2 EPB41L5 LMO7 LIMCH1 CDH1

1.02e-061982329532b7ef4ad46fe35ad2c6bdf89f70a17f1a2e2e2
ToppCellBronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ARHGAP32 DAPK2 VEPH1 EPB41L5 LMO7 RAI14 LIMCH1 CDH1 PDZD2

1.06e-0619923295f7da3eab58ace6cddb3179a415cd839d5767958
ToppCellLPS_IL1RA_TNF-Epithelial_alveolar-AT_1-AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

DAPK2 EFEMP1 FMO2 POLD2 VEPH1 AP1M2 EPB41L5 LMO7 CDH1

1.06e-0619923298c9ec5f05b79cf5ae1bf7aade603c171fb0226a9
ToppCellParenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

EPS8 DAPK2 VEPH1 EPB41L5 LMO7 RAI14 LIMCH1 CDH1 PDZD2

1.06e-0619923298587bd98de7767a575088afbea07a1feb4516b9b
ToppCellParenchymal-10x5prime-Epithelial-Epi_alveolar-AT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

DAPK2 EFEMP1 FMO2 VEPH1 EPB41L5 LMO7 LIMCH1 CDH1 SEMA3E

1.06e-061992329aca81a879ef9c196bd1885eff4c63ffe6c9682b7
ToppCelldistal-Epithelial-Alveolar_Epithelial_Type_1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

DAPK2 EFEMP1 PTPRQ FMO2 EPB41L5 LMO7 LIMCH1 CDH1 SEMA3E

1.11e-062002329cbe3e107ac16c17687d73ebb04c39d51aba1fa98
ToppCellControl|World / group, cell type (main and fine annotations)

DAPK2 VEPH1 EPB41L5 LMO7 LIMCH1 CDH1 MUC5AC PDZD2

2.90e-061682328a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCellChildren_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

DCHS2 NHS NPAS2 FMO2 NTF3 PLEKHG4B PDE8B MUC5AC

3.60e-061732328464267a2ff3f5c387b6c9c6fa4dab135a221f448
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

TRPM3 PCDH15 NHS PSAT1 SLC2A9 SLC17A1 ENPEP PDZD2

3.60e-0617323288888434641ea554a9b62c436e87920378eef29cd
ToppCellControl-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations)

DAPK2 PTPRQ EPB41L5 LMO7 LIMCH1 CDH1 SEMA3E PDZD2

3.76e-061742328548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCellTCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9

CENPC FAT2 EEA1 ABI1 VPS4B ZDHHC5 BAZ1A CRYBG3

3.92e-0617523280cc215109d9915af47e4d0a120ce2e46910715fa
ToppCell356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells)

PTPRQ PCDH15 PLEKHH2 BICC1 MXRA5 FMO2 LIMCH1 ENPEP

4.27e-0617723288220cc2fc0ee8764a67a3be51d75248be2453040
ToppCell356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells)

PTPRQ PCDH15 PLEKHH2 BICC1 MXRA5 FMO2 LIMCH1 ENPEP

4.27e-0617723287617270f49cd6b7ba66db72d20560cee985012b2
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

DAPK2 PTPRQ FMO2 EPB41L5 LMO7 LIMCH1 SEMA3E PDZD2

4.64e-0617923284f6ca313b78aa93557937a046c44dcf8bcc9963c
ToppCellLV|World / Chamber and Cluster_Paper

SYNPO2 PKP2 ECT2L LMO7 MYOM2 LIMCH1 RPL3L PDZD2

4.83e-0618023285ac6f485a58bb29462fec02dfbe8eb70864eafe3
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

DLGAP2 TRPM3 PTPRQ PCDH15 WNT9B GRM7 PTPRT PDZD2

5.03e-061812328c80ffa2ded5975a88e9a1a7d333196f95237bf0a
ToppCelldroplet-Thymus-nan-24m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NCKAP1 CENPE ARHGAP11A ANKRD28 SHCBP1L KIF20B PDE8B TENM1

5.24e-06182232839f9b3eb22293cc27c6e175702c77d1eeb24fdc9
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DLGAP2 TRPM3 PCDH15 SLC2A9 SLC17A1 TENM1 ENPEP PDZD2

5.46e-061832328facd6dbe0851b537d70a899ac7485714ab27d071
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DAPK2 EFEMP1 TRPM3 PKHD1 FMO2 VEPH1 LMO7 CDH1

5.68e-061842328cdf6f1c6cce97a7effa0c55959652e2c0b6992b3
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor

DAPK2 PTPRQ EPB41L5 LMO7 LIMCH1 CDH1 SEMA3E PDZD2

5.91e-0618523281c222f7285d6e3dae0354dc7e853ddc0ea55e63e
ToppCellControl-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARHGAP32 DAPK2 TRPM3 VEPH1 LMO7 RAI14 LIMCH1 CDH1

5.91e-0618523280d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCellCOVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type

TRPM3 PKHD1 NHS BICC1 SLC2A9 SLC17A1 UGT2A3 ENPEP

5.91e-0618523281bbc2ba8a20f72f61981b1301cdd6018cdd9150d
ToppCellCOPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class

DLGAP2 PHYHIP EFEMP1 PTPRQ BICC1 NPAS2 PKHD1L1 HAS1

5.91e-06185232823579988036fc1925992c31919750f9b3fe9f790
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

TRPM3 PCDH15 PKHD1 NHS NPAS2 SLC2A9 SLC17A1 PDZD2

6.39e-0618723283ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

TRPM3 PKHD1 NHS BICC1 SLC2A9 SLC17A1 UGT2A3 ENPEP

6.39e-0618723289d77ca45f7563bd6f2a0c1be5d99d93ad30983f7
ToppCell15-Distal-Epithelial-Secretory_progenitor|Distal / Age, Tissue, Lineage and Cell class

DAPK2 EFEMP1 TRIM36 VEPH1 LMO7 CDH1 MUC5AC SEMA3E

6.65e-0618823289a64fb07de611de38d6f24673feb3b81a5e85384
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

DAPK2 EFEMP1 PTPRQ VEPH1 EPB41L5 LMO7 CDH1 SEMA3E

6.65e-061882328eea652bab161f19148a883e7e3fe2523b36b3cea
ToppCellRA-10._Endothelium_II|RA / Chamber and Cluster_Paper

ITGA1 BMP6 BMX TRPM3 PCDH15 TCF4 PKHD1L1 IL6ST

6.91e-061892328c81787a8c662db5d7814c583dd64562857629e81
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

TRPM3 PKHD1 NHS BICC1 SLC2A9 SLC17A1 UGT2A3 ENPEP

6.91e-06189232828b502611829e4a24caff2562545c7db97686099
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor

DAPK2 FMO2 EPB41L5 LMO7 LIMCH1 CDH1 SEMA3E PDZD2

6.91e-0618923285a04cb25f8f0447b2cecdb6c3695029281aca26d
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ITGA1 TCF4 DPYSL2 ESM1 LIMCH1 PCDHGA8 IL6ST TDRD12

6.91e-061892328e60a3d6aa84788c29f23439f1c747431ea581bc3
ToppCellRV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper

SYNPO2 DAPK2 PKP2 LMO7 MYOM2 LIMCH1 RPL3L PDZD2

6.91e-0618923285e80c47f63980904c4c1ff02c201b67b456a0974
ToppCellASK428-Epithelial-Transformed_epithelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq

TRO GLI3 BICC1 EVC2 MXRA5 ABCB5 PKHD1L1 HAS1

6.91e-06189232887189275234b5d59484c58acbb14a09903f2b578
ToppCellCOVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type

TRPM3 PKHD1 NHS BICC1 SLC2A9 SLC17A1 UGT2A3 ENPEP

6.91e-0618923280be5c669b6b308bd98ddb70c84877c62a6244bbd
ToppCellE17.5-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

DAPK2 PKP2 DPYSL2 PSAT1 EPB41L5 LMO7 CDH1 SEMA3E

7.18e-06190232815f314517ed47b12d287a12a7d18cb383310e25a
ToppCellLV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper

SYNPO2 PKP2 ECT2L LMO7 MYOM2 LIMCH1 RPL3L PDZD2

7.18e-061902328de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCellRV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper

SYNPO2 DAPK2 PKP2 LMO7 MYOM2 LIMCH1 RPL3L PDZD2

7.18e-061902328fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NRIP1 B4GALNT1 NBEAL1 RASA2 APOB ZNF106 PHF3 CDH1

7.47e-06191232860c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCellChildren_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor

DAPK2 VEPH1 EPB41L5 LMO7 RAI14 LIMCH1 CDH1 PDZD2

7.47e-061912328e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NRIP1 B4GALNT1 NBEAL1 RASA2 APOB ZNF106 PHF3 CDH1

7.47e-06191232809db184cb90fe282a14474d7217068c58092c6f8
ToppCellLV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper

SYNPO2 DAPK2 PKP2 ECT2L LMO7 MYOM2 LIMCH1 PDZD2

7.47e-06191232825f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCellP07-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

DAPK2 EFEMP1 PKP2 PSAT1 AP1M2 EPB41L5 LMO7 SEMA3E

7.47e-0619123280f360766490bef3495c42f6421b22a988cfc68fb
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NRIP1 B4GALNT1 NBEAL1 RASA2 APOB ZNF106 PHF3 CDH1

7.47e-061912328973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCellEpithelial|World / Lineage, Cell type, age group and donor

DAPK2 VEPH1 EPB41L5 LMO7 RAI14 LIMCH1 CDH1 PDZD2

7.76e-061922328499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCellAdult-Epithelial|Adult / Lineage, Cell type, age group and donor

DAPK2 VEPH1 EPB41L5 LMO7 RAI14 LIMCH1 CDH1 PDZD2

7.76e-061922328efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
DrugPhenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; PC3; HT_HG-U133A

B4GALNT1 EEA1 NCR2 NPAS2 TCF4 RARA ABHD18 LMO7 PHF3 PDE8B QSER1 IL6ST

4.81e-07193223126699_DN
DrugClomiphene citrate (Z,E) [50-41-9]; Down 200; 6.6uM; PC3; HT_HG-U133A

DBT NEB GEMIN8 MLLT10 ZNF768 PITPNM1 LMO7 BAZ1A PHF3 TENM1 PCNX1 CDH1

5.37e-07195223126648_DN
DrugGabexate mesilate [56974-61-9]; Down 200; 9.6uM; PC3; HT_HG-U133A

ITGA1 DBT MAP3K5 TCF4 ABHD18 IDH2 MLLT10 PHF3 PDE8B PCNX1 LIMCH1

3.75e-06195223114220_DN
DrugEthoxyquin [91-53-2]; Down 200; 18.4uM; HL60; HT_HG-U133A

MON2 CDHR2 DBT NEB EEA1 RARA CEP162 MLLT10 PHF3 SLC25A44 MYB

4.13e-06197223112559_DN
DrugEquilin [474-86-2]; Down 200; 15uM; HL60; HT_HG-U133A

CDHR2 ITGAM TTLL1 TRIM36 GCFC2 MLLT10 ZNF768 SLC25A44 IL1RL1 QSER1 KAT6B

4.13e-06197223113039_DN
Drug1,4-bis-(phenoxyacetyl)piperazine

CLTCL1 NCKAP1 MAP3K5 GGA3 NFIL3 AP1M2 MLLT10 GRM6 ABI2 ENPEP EPB42

1.46e-0522522311CID001008511
DrugEnilconazole [35554-44-0]; Down 200; 13.4uM; MCF7; HT_HG-U133A

B4GALNT1 DBT RIPOR1 NCR2 SENP5 RARA RASA2 CEP162 IDH2 PCNX1

2.28e-05194223106518_DN
DrugMinaprine dihydrochloride [25953-17-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A

SCN11A DAPK2 NEB RARA NTF3 EPB41L5 GRM7 PCNX1 ENPEP HERC5

2.38e-05195223104814_UP
DrugChlorprothixene hydrochloride [6469-93-8]; Down 200; 11.4uM; PC3; HT_HG-U133A

DBT MAP3K5 TCF4 GCFC2 CEP162 MLLT10 ORC1 PHF3 PDE8B LIMCH1

2.49e-05196223106692_DN
DrugBucladesine sodium salt [16980-89-5]; Up 200; 7.8uM; PC3; HT_HG-U133A

BCAS3 NEB ZZEF1 MAP3K5 GEMIN8 ZBTB18 TCF4 MLLT10 LMO7 TENM1

2.71e-05198223105886_UP
Drug(+,-)-Synephrine [94-07-5]; Down 200; 24uM; MCF7; HT_HG-U133A

DBT MAP3K5 PAPOLA PGP IDH2 ECPAS PDE8B PCNX1 LIMCH1 MYB

2.71e-05198223103578_DN
DrugMinoxidil [38304-91-5]; Up 200; 19.2uM; HL60; HG-U133A

COPS2 NCR2 ZNF426 GCFC2 KIF20B ERLIN2 RNF2 SLC25A44 PCNX1 NNT

2.83e-05199223101996_UP
Diseaseprimary ovarian insufficiency (implicated_via_orthology)

USP17L21 USP17L20 USP17L19 USP17L18 USP42 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

2.26e-174623013DOID:5426 (implicated_via_orthology)
Diseasecongenital heart disease (implicated_via_orthology)

USP17L21 USP17L20 USP17L19 USP17L18 USP42 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15

7.33e-156923013DOID:1682 (implicated_via_orthology)
Diseaseintraocular pressure measurement

BCAS3 EFEMP1 FAM186A PKHD1 BICC1 NPAS2 FNDC3B TCF4 MXRA5 WNT9B NPLOC4 ZNF106 FEZ2 LMO7 SEMA3E

1.25e-0550923015EFO_0004695
DiseaseAcute Promyelocytic Leukemia

DAPK2 ITGAM FNDC3B RARA IDH2

2.91e-05462305C0023487
DiseaseMicrolissencephaly

TRAIP KATNB1 TCF4 ORC1

1.23e-04332304C1956147
Diseasebody weight

NBEAL1 ZZEF1 BMP6 EFEMP1 NFIL3 PCDH15 ZNF638 ANAPC16 PGP POLN RASA2 MLLT10 GRM7 VIRMA PTPRT CRB1 FEZ2 PHF3 ASXL3 DDX20 KAT6B CCDC152 PDZD2

1.48e-04126123023EFO_0004338
DiseaseMyopia

NRIP1 DLGAP2 SCN11A BCAS3 EFEMP1 TRPM3 BICC1 GRM7 NPLOC4 ZNF106 SEMA3E

2.38e-0438523011HP_0000545
DiseaseChronic myeloproliferative disorder

CENPE TRAIP ORC1

4.13e-04192303C1292778
DiseaseColorectal Carcinoma

CHD1 BMP6 EFEMP1 GLI3 PKHD1 DPYSL2 EVC2 ABCB5 APOB PTPRT LMO7 TENM1 CDH1 IL6ST EXOC4

4.41e-0470223015C0009402
Diseasehereditary sensory neuropathy (implicated_via_orthology)

SCN11A CCT4

5.96e-0452302DOID:0050548 (implicated_via_orthology)
DiseaseSeckel syndrome

CENPE TRAIP ORC1

6.45e-04222303C0265202
Diseasecentral corneal thickness

BCKDK EFEMP1 GLI3 BICC1 FNDC3B TCF4 NPLOC4 ZNF106 FEZ2

7.61e-043092309EFO_0005213
DiseaseCongenital Pain Insensitivity

SCN11A CLTCL1

1.24e-0372302C0002768
Diseaseglaucoma

BCAS3 EFEMP1 PKHD1 BICC1 FNDC3B LMO7

1.35e-031542306MONDO_0005041
Diseaseresponse to angiotensin receptor blocker

EPS8 BCAS3 BICC1

1.62e-03302303EFO_0010735
Diseasecommon bile duct neoplasm (is_marker_for)

APOB MUC5AC

1.64e-0382302DOID:4608 (is_marker_for)
Diseaselower face morphology measurement

DCHS2 BCAS3 CRB1 GCC2 MYOM2

1.67e-031092305EFO_0010948
DiseaseSeizures

ATP7A KATNB1 DBT TRPM3 RALA TCF4 IDH2

1.68e-032182307C0036572
DiseaseSevere Congenital Microcephaly

TRAIP TCF4 ORC1

1.79e-03312303C3853041
Diseaseurate measurement

BCAS3 TRAIP PKHD1 ANKRD28 HFM1 BICC1 TCF4 SLC2A9 IDH2 PTPRT FAF1 SLC17A1 USP17L6P WDR82 RAI14 TDRD12

1.87e-0389523016EFO_0004531
DiseaseDNA methylation

DCHS2 PIK3CG GLI3 PKHD1 EEA1 DNHD1 FNDC3B EVC2 SLC2A9 FABP12 PLEKHG4B OR6B2 EXOC4

2.05e-0365623013GO_0006306
DiseaseHeadache, glucose measurement

ZNF638 FAF1

2.10e-0392302EFO_0004468, HP_0002315
DiseaseDiuretic use measurement

NRIP1 BCAS3 FAM186A TRIM36 BICC1 ENPEP

2.17e-031692306EFO_0009928
Diseasemalignant epithelial tumor of ovary

SYNPO2 ZBTB18 MLLT10

2.55e-03352303MONDO_0018364
Diseasecystic kidney disease (implicated_via_orthology)

IFT172 BICC1

2.61e-03102302DOID:2975 (implicated_via_orthology)
Diseasecortical thickness

MON2 B4GALNT1 NBEAL1 BMP6 GLI3 PKHD1 TRIM36 TCF4 DPYSL2 MLLT10 KIF20B FAF1 ZNF106 BAZ1A QSER1 CFAP57 EXOC4 PDZD2

2.93e-03111323018EFO_0004840
Diseasecorneal resistance factor

BCKDK EFEMP1 TRPM3 GLI3 BICC1 FNDC3B TCF4 NPLOC4 ZNF106 FEZ2

3.01e-0345123010EFO_0010067
Diseasepulse pressure measurement

NRIP1 NCKAP1 NBEAL1 ITGA1 BMP6 EFEMP1 TRPM3 ZNF638 BICC1 NPAS2 LETM2 FNDC3B TCF4 MXRA5 WNT9B FRYL FAF1 ABI2 NNT ENPEP KDM1A

3.07e-03139223021EFO_0005763
Diseaseinterleukin 1 receptor-like 1 measurement

NPAS2 IL1RL1

3.18e-03112302EFO_0008168
Diseaseuric acid measurement

BCAS3 ANKRD28 HFM1 BICC1 NPAS2 TCF4 SLC2A9 ZDHHC5 FAF1 CRB1 SLC17A1 RAI14

3.19e-0361023012EFO_0004761
DiseaseAstigmatism

DLGAP2 BICC1 GRM7 NPLOC4 LMO7

3.47e-031292305HP_0000483
Diseasefacial morphology measurement

DCHS2 GLI3 PKHD1 TCF4 DPYSL2 GRM7 PTPRT CRB1 ZNF106 GCC2

3.79e-0346623010EFO_0007841
Diseasereticulocyte measurement

ITGA1 MAP3K5 USP42 NFIL3 LETM2 FNDC3B RASA2 CLASP1 RFC1 USP37 ECPAS FAF1 USP10 BAZ1A RAI14 CDH1 PDZD2

3.87e-03105323017EFO_0010700
Diseasepost-traumatic stress disorder symptom measurement

TRAIP PIK3CG TCF4 SPACA1

3.91e-03822304EFO_0008535
DiseaseIschemic stroke

DCHS2 ZNF77 USP28 GRM7 PTPRT ZNF106 PCNX1 ENPEP

4.08e-033242308HP_0002140
Diseaserenal cell carcinoma

ANAPC16 FAF1 PDZD2

4.29e-03422303EFO_0000681
Diseaseoral microbiome measurement

SLC2A9 NRDC PDZD2

4.29e-03422303EFO_0801229
DiseaseDEAFNESS, AUTOSOMAL RECESSIVE (disorder)

EPS8 PTPRQ

4.46e-03132302C1846647
Diseasecortical surface area measurement

MON2 TRPM6 DCHS2 NBEAL1 BMP6 GLI3 PKHD1 ZBTB18 TCF4 DPYSL2 ABI1 CEP162 FRYL KIF20B NPLOC4 FAF1 ZNF106 QSER1 KDM1A PDZD2

4.49e-03134523020EFO_0010736
DiseaseAgents acting on the renin-angiotensin system use measurement

NRIP1 BCAS3 BCKDK PKHD1 TRIM36 BICC1 PCNX1 ENPEP

4.97e-033352308EFO_0009931
Diseasediabetic retinopathy (biomarker_via_orthology)

ITGAM PIK3CG KDM1A

5.21e-03452303DOID:8947 (biomarker_via_orthology)
Diseaserhinitis (is_marker_for)

CRHR2 IL1RL1 MUC5AC

5.54e-03462303DOID:4483 (is_marker_for)
DiseaseGastrointestinal Stromal Sarcoma

IFT172 GLI3 SDHA

5.89e-03472303C3179349
Diseaseunipolar depression, information processing speed, cognitive function measurement

DLGAP2 PCDH15 GRM6

5.89e-03472303EFO_0003761, EFO_0004363, EFO_0008354
Diseaseresponse to platinum based chemotherapy, magnesium measurement

PCDH15 RAI14

5.94e-03152302EFO_0004647, EFO_0004845
DiseaseDegenerative polyarthritis

BMP6 SDHA DPYSL2 IDH2

6.11e-03932304C0029408
DiseaseOsteoarthrosis Deformans

BMP6 SDHA DPYSL2 IDH2

6.11e-03932304C0086743
Diseasemyocardial infarction

NBEAL1 BCAS3 ITGA1 ZNF77 FNDC3B VEPH1 APOB PDZD2

6.42e-033502308EFO_0000612
Diseaseage at onset, Myopia

NRIP1 TRPM3 BICC1 GRM7 NPLOC4

6.54e-031502305EFO_0004847, HP_0000545
Diseasemultisite chronic pain

TRAIP MLLT10 FAF1 DDX20

6.58e-03952304EFO_0010100
Diseaseocular hypertension, response to triamcinolone acetonide

GCFC2 SLC2A9 KIF20B

6.61e-03492303EFO_0006954, EFO_1001069
Diseasedevelopmental disorder of mental health (implicated_via_orthology)

NCKAP1 TCF4 RNF2

6.61e-03492303DOID:0060037 (implicated_via_orthology)
DiseaseC-reactive protein measurement

DCHS2 IFT172 TRAIP BCL7B ITGA1 ZZEF1 PAPOLA PCDH15 SHE HFM1 TCF4 APOB MLLT10 ZNF106 SLC25A44 DDX20 IL1RL1 QSER1

6.65e-03120623018EFO_0004458
DiseaseT-Cell Lymphoma

ASXL3 KDM1A

6.76e-03162302C0079772
Diseaseautosomal recessive polycystic kidney disease (implicated_via_orthology)

PKHD1 BICC1

6.76e-03162302DOID:0110861 (implicated_via_orthology)
DiseaseGastrointestinal Stromal Tumors

IFT172 GLI3 SDHA

7.00e-03502303C0238198
Diseasepre-malignant neoplasm (biomarker_via_orthology)

GLI3 MAPK9

7.62e-03172302DOID:0060071 (biomarker_via_orthology)
Diseasesphingomyelin 14:0 measurement

PAPOLA TRPM3

7.62e-03172302EFO_0010390

Protein segments in the cluster

PeptideGeneStartEntry
YRNETSSQESKNLST

C2orf16

1491

Q68DN1
NRDSALKSYSIENVT

C21orf62

176

Q9NYP8
LKSYSIENVTSIANN

C21orf62

181

Q9NYP8
SIQDVTQESKAVYST

ESYT1

506

Q9BSJ8
LTDSNTKYVGNNIST

EPB42

406

P16452
ESVFSYQVASTLKQV

ANAPC16

56

Q96DE5
YLVATTSKNANASLV

AP1M2

66

Q9Y6Q5
SAVTRNYSEKSINSI

COPS2

101

P61201
DKYASAEARQTQSVL

CRYBG3

2011

Q68DQ2
AQYNISALVTIATKT

B4GALNT1

271

Q00973
ANDATTARYTTAVSK

ADGRG4

716

Q8IZF6
TTISNNIKYGRDDVT

ABCB5

476

Q2M3G0
SSSTTLAQYDNESKK

BMX

186

P51813
EVKSASTQKRYTFTN

GVINP1

2011

Q7Z2Y8
FNQTLSTNKSGYTSR

ABHD18

306

Q0P651
TFNAINRYTNTSKTV

ANKRD28

996

O15084
NRYTNTSKTVSFEAL

ANKRD28

1001

O15084
ALEETKAYTTQSLAS

ABI1

46

Q8IZP0
IETYKNVTDSSRFNR

ANKEF1

456

Q9NU02
STLTVSQAKEAYRKS

DLGAP2

371

Q9P1A6
STIRSTAAVSYTNYK

DLGAP2

596

Q9P1A6
RTSKTTYQFIASVAL

ECT2L

836

Q008S8
TQLVRASKDLAQTSY

CCNT1

161

O60563
NSVICTRTYEKVSSN

FABP12

121

A6NFH5
SRTSSQSKGNKSYLE

DDX20

661

Q9UHI6
VVQSADLKTSSDSLY

DNHD1

596

Q96M86
NIQSYTATVISAAKT

BCAS3

261

Q9H6U6
RSKTVTSFYNQSAID

BCKDK

46

O14874
SVSDVYQLKVDSSTN

BCL7B

96

Q9BQE9
ISQTYNISVSFKQRS

BICC1

231

Q9H694
SSRRQATVNVSYKED

CHD1

231

O14646
TGIKVSYEQRQRSAS

ATG2B

581

Q96BY7
SEVSSTENTDKYNQR

ASXL3

651

Q9C0F0
ALEETKAYTTQSLAS

ABI2

46

Q9NYB9
VANKQTLASYRSKAT

BAZ1A

291

Q9NRL2
NFRVIATKSSEQSRS

BAZ1A

1376

Q9NRL2
NYTVNILGETKSSRS

ADNP2

136

Q6IQ32
SLENRSAIVKYNASS

ATP7A

311

Q04656
SITVKVNSTYGNSSR

POLN

376

Q7Z5Q5
KRLSQISAGETEYNT

NBEAL1

2676

Q6ZS30
YSTSSSKRQSQQLEA

RAI14

906

Q9P0K7
VNYVETSAKTRANVD

RALA

151

P11233
GKYTTNNSSEQRVSL

RARA

206

P10276
RSSSYTRKSQFQVEE

RASA2

231

Q15283
QKTSQVSVELAQSYS

QSER1

251

Q2KHR3
SQSQVLSVVSLSESY

QSER1

446

Q2KHR3
KADDRYSQSVIRSNS

QSER1

601

Q2KHR3
RSSDKVVLVSNYTQT

RAD54L

511

Q92698
QTYSQEVSLTADSRK

PCDHGA8

751

Q9Y5G5
ALLSIYKQTQAASAS

NCLN

151

Q969V3
KYLRSQSDLTSTTNN

KAT6B

131

Q8WYB5
VSRTGRQVKYAQSQT

NPAS2

696

Q99743
VQSDKASVTITSRYD

DBT

101

P11182
YSVQVADSTFTVLKR

MAPK9

11

P45984
ASTQLSSYVKQVQTG

LETM2

251

Q2VYF4
ATSAEKRSLVLQNYT

GLI3

1036

P10071
SKSAVEDSTLSRYSQ

LSM11

241

P83369
QRALSTTTSVDVSYK

MAGEB3

66

O15480
DNSVSKSVRFYLVVS

NCR2

116

O95944
TDTTNITKYALNTTT

MGAM2

2476

Q2M2H8
KYSNLVQSVLSSRGV

MGME1

51

Q9BQP7
QSLLTSISTSVSYQA

ERVS71-1

366

P61550
RYSSRIQASTKEDQA

GEMIN8

101

Q9NWZ8
VAVTSTNAAKVFNLY

DPYSL2

381

Q16555
LQQSESSNYVRLTSK

LRRC53

771

A6NM62
ETLVASTSKNQLYSI

CFAP57

351

Q96MR6
VNSRIQSKTERGSYS

TCF4

96

P15884
SQSNKRSIYKAISSN

FANCM

601

Q8IYD8
SQSNVSSYVVDLTRV

KATNB1

291

Q9BVA0
ENRYKTITFSANVSS

FSIP2

1866

Q5CZC0
VYISADSKSSNSNVI

ECE2

281

P0DPD6
ENKTYSSVRTEALSV

ECPAS

1776

Q5VYK3
STQSRDSINKAKYLT

POLD2

251

P49005
RDTNSTVSSYKSEQT

PCNX1

391

Q96RV3
KASEYTVSIQSNVSK

FAT2

2586

Q9NYQ8
VIARSTYQESKEANS

PDZD2

826

O15018
SSSLQTAIRKAEYSQ

PDZD2

2171

O15018
ITNNSSKTRAAYAEK

PGP

66

A6NDG6
RFTIYSKNATVGQSV

PEX2

66

P28328
QTCYTSVKQVSSAEV

PDE8B

106

O95263
STAYAQEIQKLSNST

NFIL3

131

Q16649
TDQKSLTQSAAQSTY

FAM205A

176

Q6ZU69
STYQETQNKSSSLST

FAM214A

596

Q32MH5
EQKAASSLVSYVRTS

FAM234B

91

A2RU67
TGLSTRNQETYETLK

FCER1G

66

P30273
INAKKVNTTTSSDSY

FRYL

846

O94915
VYINRNKTGEITASS

NPLOC4

46

Q8TAT6
KTYSLRSQASIIGVN

KIF20B

1706

Q96Q89
LEQIKIISSSSDYQT

VEPH1

36

Q14D04
ASTTSETIQYRKAVK

CRHR2

296

Q13324
QFQKASRVTETLSAY

EVC2

971

Q86UK5
IYNSEKSSNLSVTTD

LMO7

1141

Q8WWI1
DLVVNTNSTSYSKEL

MANSC4

181

A6NHS7
VSKFNTQNYARTSVI

NRIP1

526

P48552
QASDNLSRVINSYKT

GGA3

281

Q9NZ52
RASIYQSVFTNSSKE

FMO6P

51

O60774
TSSSQARKYVNAFSA

MYB

621

P10242
SGVLIQQSSSYTKVE

MUC5AC

166

P98088
QQSSSYTKVEARLGL

MUC5AC

171

P98088
TTYTENGQVKSIVAT

ENPEP

206

Q07075
VLNTTTAATLSNKSY

MON2

621

Q7Z3U7
TAATLSNKSYSVQGQ

MON2

626

Q7Z3U7
VSLTVKNTKDSAYNT

ITGA1

841

P56199
QCKTSQTYVRALTSE

NTF3

216

P20783
GKRQSSVTVVSQYDN

ARHGAP32

2011

A7KAX9
SKTIATSQNRIYLTA

PHB2

261

Q99623
KAANIQTSESETRLY

PLEKHH2

71

Q8IVE3
ESVNKNSAATLSYTT

PLEKHH2

571

Q8IVE3
QETDKTTTRNRESVY

NCKAP1

1071

Q9Y2A7
ITSYKSVQTTLQTDE

ERLIN2

56

O94905
QVTISADKSISTAYL

IGHV5-51

86

A0A0C4DH38
YATRSAAQSVKQLET

IFT172

1541

Q9UG01
TTRTNSSNLQYKEAL

METTL27

166

Q8N6F8
NLTYESISSTAINVS

PTPRQ

1101

Q9UMZ3
TVSVADTAQRSVSKY

PTPRT

251

O14522
SNENISYRILSSSKE

DCHS2

2476

Q6V1P9
GSSITVNQTNKRDYV

HERC5

851

Q9UII4
TSNLKITNEDTNYIS

HFM1

71

A2PYH4
QSFTDTVYRQAINSK

PAPOLA

461

P51003
SSYITAIKNSSVLEQ

ORC1

761

Q13415
EADIKYTQSASTLSA

PAX1

346

P15863
TSNGSIYTAVKLNRE

PCDH15

766

Q96QU1
KKLQSQYASSEATIS

EEA1

256

Q15075
VKRSTTQVADSGYQR

EXOC4

311

Q96A65
EANTYLNSKSTRSSV

APOB

3516

P04114
AINAALTQATRTTVY

CDHR2

1066

Q9BYE9
TEYQTTKTNKARRST

EPB41L5

351

Q9HCM4
NYSVTATRSFTVKDE

IL1RL1

191

Q01638
VTIDSALATQKYSVA

IDH2

96

P48735
KEQYTIINRTASSVT

IL6ST

76

P40189
TAQSAEKIYIQTTTL

GRM6

806

O15303
NTRSTSQTFIYKCDA

KDM1A

606

O60341
AYNEAAVSILNSSTR

CASD1

231

Q96PB1
ENDYRVSTSKITKQS

CCDC138

111

Q96M89
YLQQLSRKDETSTSG

GCFC2

376

P16383
SSAQKRETYTFENSV

CENPC

176

Q03188
TKQETLANITAVSYD

DAPK2

231

Q9UIK4
SIENSIYRTAFKLQS

DYTN

11

A2CJ06
STQYKFRLTASNTEG

FNDC3B

541

Q53EP0
VSSASTYTQSLEQLL

GCC2

1526

Q8IWJ2
AEQVSSYNESKRSES

GPALPP1

261

Q8IXQ4
RVSSASDYNSSELKT

BMP6

396

P22004
LARVQTKSKSYQDST

CCDC152

191

Q4G0S7
SSSLSQDDKINKTYR

CEP162

456

Q5TB80
AATARSVALTISAYQ

HAS1

91

Q92839
QYSVTKSSNRFVSLT

ESM1

136

Q9NQ30
RASIYQSVVTNTSKE

FMO2

51

Q99518
ETKNRTYAEISQAFS

SLC2A9

501

Q9NRM0
TAQSAEKLYIQTTTL

GRM7

811

Q14831
TLIRKQESYNSESSV

DDX53

111

Q86TM3
EQRKNYARDSVSSVS

EPS8

46

Q12929
FSGSSTIQEVKRNVY

FAF1

211

Q9UNN5
STLENNAIKYISSTI

FAM186A

251

A6NE01
NAIKYISSTIVNLST

FAM186A

256

A6NE01
SVVTSNKRATQGTYS

CRB1

1366

P82279
QSEQSSVRYKDSTSL

SPACA1

261

Q9HBV2
TKDDLATTQSNYKST

CENPE

801

Q02224
DSAQTRYIKTSGNAT

RNF2

241

Q99496
VKNSTYTALIIATDN

CDH1

556

P12830
QEIQTLKRSSTGSYE

FEZ2

196

Q9UHY8
QDTSNRVTVKSLDYS

LIMCH1

106

Q9UPQ0
DSQSSNKLISAVYTV

OR6B2

266

Q6IFH4
LKVAQASSSQYFRES

MAP3K5

261

Q99683
RSTEAAIKYFLTQAT

MT-ND2

51

P03891
ATQASTLYSNNITKL

NNT

381

Q13423
TTIYANTINTFRIKS

EFEMP1

416

Q12805
KIRNSNFYTVAVTSL

TMEM106C

141

Q9BVX2
KSQTESIQQDYTTIL

UTP20

1531

O75691
DSVNASLRSTTVYKQ

ARHGAP11A

936

Q6P4F7
SVTSTDISSLYAKAQ

TRMT1L

396

Q7Z2T5
TSKIIQDLENSSTYA

TRIM36

471

Q9NQ86
KNSRTSLASASNENY

TMC3

251

Q7Z5M5
SQAQSSSESYKERVA

TAAR9

236

Q96RI9
KRASAKVSDSISAQY

SDHA

41

P31040
NKSVSRQYSTEDTIL

NHS

1186

Q6T4R5
NNASTSYDVTAKSIT

RPL3L

301

Q92901
SYVELNASDTRSKSS

RFC1

671

P35251
AIVKSITSSADQYLA

TDRD12

76

Q587J7
TNLSSLKTSVIDYNV

TDRD12

1051

Q587J7
SISEKEYITSSLVQQ

SLC17A1

231

Q14916
ILSYAASSQQATLKS

SPATA31A7

1261

Q8IWB4
SSIKSQTIYEIIDNS

PSAT1

271

Q9Y617
RKANKISYQSSSTEE

SEMG1

281

P04279
VKGTRTTSNNTYEVE

POLR3A

1241

O14802
INTNTYTSQDLKSAL

SIL1

121

Q9H173
YQDSSSRFKVTVSVA

SHCBP1L

191

Q9BZQ2
SATTSLNSKVVSQYS

CCT4

166

P50991
TATSTIYILKQENTQ

TENM1

1701

Q9UKZ4
RTEYSVAVQTAVKQS

PHYHIP

81

Q92561
TDSRNKTTTVNYVRD

PKHD1

2591

P08F94
LTRKFVADYSQSNTV

SLC25A44

96

Q96H78
VADYSQSNTVKSLVA

SLC25A44

101

Q96H78
TKYLNFTASENTSRV

ITGAM

936

P11215
VTTEKTYTSTSNNSI

MLLT10

261

P55197
EYQAAVDNSRKASST

CLTCL1

1236

P53675
LYIKRAQTTNSNSSS

CLASP1

1516

Q7Z460
SLSAEKYDVSSQVIS

PIK3CG

751

P48736
AVATVIARTNQAYSA

PITPNM1

531

O00562
ILSYAASSQQATLKS

SPATA31A3

1261

Q5VYP0
SYLAKAVATEANNST

VPS4B

181

O75351
TVTLSNRIISFYDSQ

SENP5

651

Q96HI0
VSTSDIRSVLSQQAY

USP42

391

Q9H9J4
NCQDSRTASVTYVKS

ZNF77

191

Q15935
QNASSSKESASVKEY

TRPM6

786

Q9BX84
NTVVYSSNKIDDTIR

WDR82

76

Q6UXN9
EESVRTQSSVSKSYI

SYNPO2

541

Q9UMS6
ILSYAASSQQATLKS

SPATA31A1

1261

Q5TZJ5
ILSYAASSQQATLKS

SPATA31A5

1261

Q5VU36
KQSSLYILISTQESS

TRO

506

Q12816
RKSQDTYILQASSAE

PLEKHG4B

1076

Q96PX9
TIQKTFTYTRTQAQH

TRPM3

421

Q9HCF6
TVKESVSTNNRVQYE

ZBTB18

296

Q99592
ASSITSVLSQQAYVL

USP17L18

356

D6R9N7
SSRYESQNTELKTQS

ZNF768

146

Q9H5H4
ASSITSVLSQQAYVL

USP17L5

356

A8MUK1
TAKVFRTYNASITLQ

TOP1MT

421

Q969P6
ASSITSVLSQQAYVL

USP17L21

356

D6R901
SVTVGTQATKYNSEV

NRDC

976

O43847
RNSQSSSVSYLESKS

PHF3

471

Q92576
ASSITSVLSQQAYVL

USP17L19

356

D6RCP7
DNSKITRSTDTQFTY

PKHD1L1

766

Q86WI1
TAQAIANTARAYEKS

USP28

746

Q96RU2
NSKNSTVTRLIYAFI

SERINC3

31

Q13530
ASSITSVLSQQAYVL

USP17L12

356

C9JPN9
TTSTSYKSLANQTRN

ZDHHC5

451

Q9C0B5
KETSRQLSYSDNQAS

USP37

131

Q86T82
SSTSVTAYKQNSAQI

ZMYM6

256

O95789
ASSITSVLSQQAYVL

USP17L24

356

Q0WX57
KLISSTESELQQSYA

ZZEF1

2566

O43149
RSVVYQQSSKESATL

USP10

611

Q14694
ALRTVITDSSYKENA

UGT2A3

426

Q6UWM9
TDSVINYTIITNKSQ

SCN11A

1211

Q9UI33
ISSKRQQLYIGSASA

SEMA3E

496

O15041
ASSITSVLSQQAYVL

USP17L6P

356

Q6QN14
VTQLYVSVDASTKDS

TYW1

526

Q9NV66
RYDSAVKVSSATNEA

WNT9B

241

O14905
NSESGNSRYSIALKT

SHE

421

Q5VZ18
ASSITSVLSQQAYVL

USP17L22

356

D6RA61
NKASTVTKRFSTYSQ

RIPOR1

336

Q6ZS17
ASSITSVLSQQAYVL

USP17L15

356

C9J2P7
SEDKEKQYTSQTTRL

VIRMA

1211

Q69YN4
EAQESVTKTTNYSTV

ZC3H14

361

Q6PJT7
GTAQYSSQKSVEERS

PKP2

126

Q99959
SKSTRNYAKASRNVE

ZNF106

556

Q9H2Y7
NIVYQRTSTQEKSFE

ZNF426

211

Q9BUY5
VQSRYTKESASSILA

ZNF638

131

Q14966
IEYGKTFNQSSTRTT

ZNF506

176

Q5JVG8
TFNQSSTRTTYKKID

ZNF506

181

Q5JVG8
TSSFVSQSNKEAYVI

TTLL1

166

O95922
ASSITSVLSQQAYVL

USP17L20

356

D6RJB6
ASSITSVLSQQAYVL

USP17L10

356

C9JJH3
SSRSKLQTVYSELDQ

TRAIP

231

Q9BWF2
ASSITSVLSQQAYVL

USP17L11

356

C9JVI0
QYKSVSEVRVSTTNS

PP2D1

516

A8MPX8
NIVSSKDYLVTANSN

LDHAL6A

76

Q6ZMR3
YTQYSQTISTKDTRQ

MXRA5

456

Q9NR99
EYASKKRASTQASSQ

MYOM2

31

P54296
TVNQTTTASRYLKVS

MYOM2

861

P54296
TTASRYLKVSDLQQG

MYOM2

866

P54296
NISSVLYSDSFRKQI

NEB

6396

P20929